serum vasoactive intestinal peptide concentration 16.1 per cent - VIP level blood test vasoactive intestinal polypeptide Understanding Serum Vasoactive Intestinal Peptide Concentration: A Comprehensive Guide

VIPoma symptoms The vasoactive intestinal peptide (VIP), also known as vasoactive intestinal polypeptide, is a crucial peptide hormone that plays a significant role in numerous physiological processes within the human body2025年8月10日—In healthy controls, amedian VIP-serum level of 42.44 +/- 2.540 pg/ml(range, 12.9-98.5 pg/ml) was found, while patients with pancreatic cancer .... Its concentration in biological fluids, particularly in the serum, can serve as a valuable indicator for various health conditions.作者：J Keller·2005·被引用次数：24—Increased VIP plasma levels cause severe secretory diarrhea. Moreover, VIP is a major regulator of humanintestinalmotility. This article delves into the intricacies of serum vasoactive intestinal peptide concentration, exploring what it means, how it's measured, and its clinical significance, drawing upon expert knowledge and scientific findings.

What is Vasoactive Intestinal Peptide (VIP)?

Vasoactive intestinal peptide is a neuropeptide with potent immunoregulatory properties.Interference With VIP to Distinguish Between Real and False ... It is found in the brain, gastrointestinal tract, and other tissues, influencing a wide range of functions, including smooth muscle relaxation, intestinal secretion, and vasodilation.作者：B Chevalier·2024·被引用次数：2—Vasoactive intestinal peptide(VIP)-secreting tumors (VIPomas) are digestive neuroendocrine tumors in which the hormonal secretion is life-threatening. Its presence is vital for maintaining homeostasis.

Measuring Serum Vasoactive Intestinal Peptide Concentration

The assessment of vasoactive intestinal peptide concentration typically involves a serum or plasma blood test. This diagnostic procedure, often referred to as a VIP level blood test, measures the amount of VIP circulating in the bloodstream. It's important to note that Vasoactive intestinal polypeptide concentration determinations are method dependent. This means that the specific assay methods or kits used can influence the results obtained. Therefore, consistency in laboratory procedures is crucial for accurate interpretation.

Normal and Elevated VIP Levels

Establishing a definitive "normal" range can be challenging due to the variability in measurement methods. However, studies provide valuable benchmarks. For instance, in healthy controls, a median VIP-serum level of 42.44 +/- 2.540 pg/ml (with a range of 12.9-98.5 pg/ml) has been reported.作者：O Belei·2023·被引用次数：2—The plasma VIPconcentrationconsistently remained at low levels in successive measurements after the surgical procedure. ... Around 70% of small- ... Other studies have indicated average serum concentrations around 16 r+ 8 pg/mL with a range of 0-64 pg/mL. More recent research has shown a median VIP level in some cohorts at 287VIPoma - StatPearls - NCBI Bookshelf - NIH.7 (interquartile range, 215.3–367.7) pg/mL.

Conversely, significantly elevated serum vasoactive intestinal peptide levels are often associated with specific medical conditions. For example, patients diagnosed with VIPoma (a VIPoma or Vasoactive Intestinal Peptide Secreting Tumor) generally exhibit heightened serum VIP levels, which can range from 60 to as high as 2100 pg/mL. Levels exceeding 200 pg/mL are frequently indicative of a VIPoma. In individuals with diarrhea where VIP-secreting tumors are identified, plasma vasoactive intestinal peptide concentrations have been observed to be greater than 140 pg/mL. In rare cases of pediatric Vasoactive Intestinal Peptide tumors, the median plasma VIP level was reported as high as 685 pg/mL, accompanied by other laboratory abnormalities such as hypokalemia.

Clinical Significance of Serum VIP Concentration

The primary clinical relevance of measuring serum vasoactive intestinal peptide concentration lies in the diagnosis and management of VIPoma. This rare neuroendocrine tumor, often originating in the pancreas or duodenum, produces excessive amounts of VIP. The resulting hypersecretion of VIP leads to a characteristic syndrome known as Verner-Morrison syndrome, primarily characterized by severe watery diarrhea, hypokalemia, and achlorhydria.Do Elevated Plasma Vasoactive Intestinal Polypeptide (VIP ... Patients with confirmed watery diarrhea should have their serum vasoactive intestinal peptide levels measured, ideally during an active bout of diarrhea, to aid in diagnosis作者：S Kumar·2008·被引用次数：4—Pathologically elevatedvasoactive intestinal polypeptide(VIP) plasma levels cause secretory diarrhea with excessive loss of..

Beyond VIPoma, research is exploring the role of VIP in other conditions. For example, altered serum VIP levels and a dysfunctional vasoactive intestinal peptide axis have been observed in certain autoimmune diseases and inflammatory conditions. Studies have investigated serum levels of vasoactive intestinal peptide as a potential biomarker for predicting the severity and progression of early arthritis. Furthermore, elevated vasoactive intestinal polypeptide plasma levels are known to cause severe secretory diarrhea and are a major regulator of human intestinal motility.

Factors Affecting VIP Levels

Several factors can influence vasoactive intestinal peptide levels, including:

* Tumor Secretion: As discussed, VIPoma is the most prominent cause of significantly elevated levels.

* Method Dependency: The assay used for measurement can introduce variability.

* Physiological State: Levels can fluctuate based on factors like stress and hydration.

* Medications: Certain drugs may impact VIP production or clearance.

* Underlying Medical Conditions: Other gastrointestinal disorders or systemic diseases might affect VIP levelsGanglioneuroblastoma as Vasoactive intestinal ....

The Importance of Expert Interpretation

Interpreting serum vasoactive intestinal peptide concentration requires a thorough understanding of clinical context, patient history, and potential confounding factors. While elevated levels in the presence of characteristic symptoms strongly suggest a VIPoma, a comprehensive diagnostic approach is essential. Healthcare professionals at institutions like UCSF Health or Cleveland Clinic utilize these tests as part of a broader diagnostic workup.Serum levels of vasoactive intestinal peptide (VIP) in ...

In conclusion, serum vasoactive intestinal peptide concentration is a critical biomarker for diagnosing and managing VIPoma and holds potential for broader applications in understanding various physiological and pathological processes. Continued research into the vasoactive intestinal peptide axis promises to further illuminate its multifaceted role in human health.